标题
Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
作者
关键词
-
出版物
Neuroscience Bulletin
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-11-28
DOI
10.1007/s12264-019-00447-9
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Orexin/hypocretin receptor, Orx1, gene variants are associated with major depressive disorder
- (2019) Mujgan Cengiz et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia
- (2019) Sander Brooks et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes
- (2019) Michael G. Gottschalk et al. Translational Psychiatry
- Effect of suvorexant on event-related oscillations and EEG sleep in rats exposed to chronic intermittent ethanol vapor and protracted withdrawal
- (2019) Manuel Sanchez-Alavez et al. SLEEP
- Hypocretin/orexin antagonists decrease cocaine self-administration by female rhesus monkeys
- (2018) Richard W. Foltin et al. DRUG AND ALCOHOL DEPENDENCE
- An overview of hypocretin based therapy in narcolepsy
- (2018) Shinichi Takenoshita et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A randomized Phase 2 study to evaluate the orexin-2 receptor antagonist seltorexant in individuals with insomnia without psychiatric comorbidity
- (2018) Peter De Boer et al. JOURNAL OF PSYCHOPHARMACOLOGY
- SB-334867 (an Orexin-1 Receptor Antagonist) Effects on Morphine-Induced Sensitization in Mice—a View on Receptor Mechanisms
- (2018) Małgorzata Łupina et al. MOLECULAR NEUROBIOLOGY
- Sex- and Age-dependent Effects of Orexin 1 Receptor Blockade on Open-Field Behavior and Neuronal Activity
- (2018) Shannon R. Blume et al. NEUROSCIENCE
- Cost-effectiveness analysis of suvorexant for the treatment of Japanese elderly patients with chronic insomnia in a virtual cohort
- (2018) Shinichi Nishimura et al. JOURNAL OF MEDICAL ECONOMICS
- Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study
- (2018) Masakazu Hatano et al. Clinical Psychopharmacology and Neuroscience
- Increased Number and Activity of a Lateral Subpopulation of Hypothalamic Orexin/Hypocretin Neurons Underlies the Expression of an Addicted State in Rats
- (2018) Morgan H. James et al. BIOLOGICAL PSYCHIATRY
- Role of Medial Hypothalamic Orexin System in Panic, Phobia and Hypertension
- (2018) Aline R. Abreu et al. BRAIN RESEARCH
- A sleeping giant: Suvorexant for the treatment of alcohol use disorder?
- (2018) Erin J. Campbell et al. BRAIN RESEARCH
- Therapeutics development for addiction: Orexin-1 receptor antagonists
- (2018) David A. Perrey et al. BRAIN RESEARCH
- Hypocretin receptor 1 involvement in cocaine-associated behavior: Therapeutic potential and novel mechanistic insights
- (2018) Zachary D. Brodnik et al. BRAIN RESEARCH
- Orexin 2 receptor stimulation enhances resilience, while orexin 2 inhibition promotes susceptibility, to social stress, anxiety and depression
- (2018) Clarissa D. Staton et al. NEUROPHARMACOLOGY
- The role of the orexin system in stress response
- (2018) Derya Sargin NEUROPHARMACOLOGY
- Optical probing of orexin/hypocretin receptor antagonists
- (2018) Shi-Bin Li et al. SLEEP
- Orexin/hypocretin receptor modulation of anxiolytic and antidepressive responses during social stress and decision-making: Potential for therapy
- (2018) Cliff H. Summers et al. BRAIN RESEARCH
- Addition of Suvorexant to Ramelteon Therapy for Improved Sleep Quality with Reduced Delirium Risk in Acute Stroke Patients
- (2018) Kei Kawada et al. Journal of Stroke & Cerebrovascular Diseases
- Orexin supplementation in narcolepsy treatment: A review
- (2018) Eugenie Nepovimova et al. MEDICINAL RESEARCH REVIEWS
- The neurobiological basis of narcolepsy
- (2018) Carrie E. Mahoney et al. NATURE REVIEWS NEUROSCIENCE
- A Novel Bio-Psychosocial-Behavioral Treatment Model of Panic Disorder
- (2018) Seon-Cheol Park et al. Psychiatry Investigation
- Effects of suvorexant on the Insomnia Severity Index in patients with insomnia: analysis of pooled phase 3 data
- (2018) W. Joseph Herring et al. SLEEP MEDICINE
- Suvorexant (Belsomra® Tablets 10, 15, and 20 mg): Japanese Drug-Use Results Survey
- (2018) Yuko Asai et al. Drugs in research & development
- Orexin Depolarizes Central Amygdala Neurons via Orexin Receptor 1, Phospholipase C and Sodium-Calcium Exchanger and Modulates Conditioned Fear
- (2018) Erik T. Dustrude et al. Frontiers in Neuroscience
- Orexin research: patent news from 2016
- (2017) Christoph Boss et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive Disorder
- (2017) Kathryn M Connor et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Suvorexant for the Treatment of Insomnia in Adolescents
- (2017) Kentaro Kawabe et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Suvorexant-Induced Dream Enactment Behavior in Parkinson Disease: A Case Report
- (2017) Hiromitsu Tabata et al. Journal of Clinical Sleep Medicine
- Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study
- (2017) Patricia Murphy et al. Journal of Clinical Sleep Medicine
- Neural Circuitry of Wakefulness and Sleep
- (2017) Thomas E. Scammell et al. NEURON
- Role of orexin receptors in the ventral tegmental area on acquisition and expression of morphine-induced conditioned place preference in the rats
- (2017) Sharareh Farahimanesh et al. NEUROPEPTIDES
- Effects of Suvorexant, a Dual Orexin/Hypocretin Receptor Antagonist, on Impulsive Behavior Associated with Cocaine
- (2017) Taylor A Gentile et al. NEUROPSYCHOPHARMACOLOGY
- Intra-LC microinjection of orexin type-1 receptor antagonist SB-334867 attenuates the expression of glutamate-induced opiate withdrawal like signs during the active phase in rats
- (2017) Bita Hooshmand et al. NEUROSCIENCE LETTERS
- Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models
- (2017) Yoko Irukayama-Tomobe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Palatable food self-administration and reinstatement are not affected by dual orexin receptor antagonism
- (2017) Shaun Yon-Seng Khoo et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data
- (2017) W. Joseph Herring et al. PSYCHOPHARMACOLOGY
- Hypocretin receptor 1 blockade produces bimodal modulation of cocaine-associated mesolimbic dopamine signaling
- (2017) K. A. Levy et al. PSYCHOPHARMACOLOGY
- Preclinical assessment of the abuse potential of the orexin receptor antagonist, suvorexant
- (2017) Stephanie Born et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Insight Into Reduction of Wakefulness by Suvorexant in Patients With Insomnia: Analysis of Wake Bouts
- (2017) Vladimir Svetnik et al. SLEEP
- Efficacy and safety of almorexant in adult chronic insomnia: a randomized placebo-controlled trial with an active reference
- (2017) Jed Black et al. SLEEP MEDICINE
- Suvorexant for the treatment of primary insomnia: A systematic review and meta-analysis
- (2017) Akira Kuriyama et al. SLEEP MEDICINE REVIEWS
- Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation
- (2017) Pascal Bonaventure et al. Frontiers in Pharmacology
- Insight Into Reduction of Wakefulness by Suvorexant in Patients With Insomnia: Analysis of Wake Bouts
- (2017) Vladimir Svetnik et al. SLEEP
- The dual orexin receptor antagonist TCS1102 does not affect reinstatement of nicotine-seeking
- (2017) Shaun Yon-Seng Khoo et al. PLoS One
- Differential roles of orexin receptors within the dentate gyrus in stress- and drug priming-induced reinstatement of conditioned place preference in rats.
- (2016) Fereshte Ebrahimian et al. BEHAVIORAL NEUROSCIENCE
- Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials
- (2016) W. Joseph Herring et al. BIOLOGICAL PSYCHIATRY
- The highly selective orexin/hypocretin 1 receptor antagonist GSK1059865 potently reduces ethanol drinking in ethanol dependent mice
- (2016) Marcelo F. Lopez et al. BRAIN RESEARCH
- Involvement of orexin-1 and orexin-2 receptors within the dentate gyrus of the hippocampus in the acquisition, expression and extinction of lateral hypothalamic-induced conditioned place preference in the rats
- (2016) Shahrnaz Parsania et al. BRAIN RESEARCH
- Review of Safety and Efficacy of Sleep Medicines in Older Adults
- (2016) Jennifer L. Schroeck et al. CLINICAL THERAPEUTICS
- Timed Inhibition of Orexin System by Suvorexant Improved Sleep and Glucose Metabolism in Type 2 Diabetic db/db Mice
- (2016) Hiroshi Tsuneki et al. ENDOCRINOLOGY
- SB-334867, an orexin receptor 1 antagonist, decreased seizure and anxiety in pentylenetetrazol-kindled rats
- (2016) Elham Kordi Jaz et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Effect of Orexin A antagonist (SB-334867) infusion into the nucleus accumbens on consummatory behavior and alcohol preference in Wistar rats
- (2016) B Ganaraja et al. INDIAN JOURNAL OF PHARMACOLOGY
- A Phase II Dose-Ranging Study Evaluating the Efficacy and Safety of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Primary Insomnia
- (2016) Kathryn M. Connor et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Assessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study
- (2016) Kerri A. Schoedel et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials
- (2016) W. Joseph Herring et al. Journal of Clinical Sleep Medicine
- Effects of Suvorexant, an Orexin Receptor Antagonist, on Respiration during Sleep In Patients with Obstructive Sleep Apnea
- (2016) Hong Sun et al. Journal of Clinical Sleep Medicine
- The role of trigeminal nucleus caudalis orexin 1 receptor in orofacial pain-induced anxiety in rat
- (2016) Mehri Bahaaddini et al. NEUROREPORT
- The blockade of GABA A receptors attenuates the inhibitory effect of orexin type 1 receptors antagonist on morphine withdrawal syndrome in rats
- (2016) Mahnaz Davoudi et al. NEUROSCIENCE LETTERS
- Orexin-A represses satiety-inducing POMC neurons and contributes to obesity via stimulation of endocannabinoid signaling
- (2016) Giovanna Morello et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dual Orexin Receptor Antagonist, Almorexant, in Elderly Patients With Primary Insomnia: A Randomized, Controlled Study
- (2016) Thomas Roth et al. SLEEP
- Effects of suvorexant on sleep architecture and power spectral profile in patients with insomnia: analysis of pooled phase 3 data
- (2016) Ellen Snyder et al. SLEEP MEDICINE
- Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoid-mediated disinhibition of dopaminergic neurons
- (2016) Li-Wei Tung et al. Nature Communications
- Dual Orexin Receptor Antagonist, Almorexant, in Elderly Patients With Primary Insomnia: A Randomized, Controlled Study
- (2016) Thomas Roth et al. SLEEP
- Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man
- (2016) Anthony L. Gotter et al. Scientific Reports
- Individual differences in orexin-I receptor modulation of motivation for the opioid remifentanil
- (2015) Kirsten A. Porter-Stransky et al. ADDICTION BIOLOGY
- Recent trends in orexin research—2010 to 2015
- (2015) Christoph Boss et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2-INDUCED PANIC-ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSES
- (2015) Philip L. Johnson et al. DEPRESSION AND ANXIETY
- Orexin-1 receptor signaling increases motivation for cocaine-associated cues
- (2015) Brandon S. Bentzley et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Effects of the orexin receptor antagonist suvorexant on respiration during sleep in healthy subjects
- (2015) Naoto Uemura et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Discovery of (1R,2S)-2-{[(2,4-Dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide (E2006): A Potent and Efficacious Oral Orexin Receptor Antagonist
- (2015) Yu Yoshida et al. JOURNAL OF MEDICINAL CHEMISTRY
- Orexin-Corticotropin-Releasing Factor Receptor Heteromers in the Ventral Tegmental Area as Targets for Cocaine
- (2015) G. Navarro et al. JOURNAL OF NEUROSCIENCE
- The Dual Hypocretin Receptor Antagonist Almorexant is Permissive for Activation of Wake-Promoting Systems
- (2015) Gregory S Parks et al. NEUROPSYCHOPHARMACOLOGY
- Effects of suvorexant, an orexin receptor antagonist, on breathing during sleep in patients with chronic obstructive pulmonary disease
- (2015) Hong Sun et al. RESPIRATORY MEDICINE
- Orexins and fear: implications for the treatment of anxiety disorders
- (2015) África Flores et al. TRENDS IN NEUROSCIENCES
- Profile of suvorexant in the management of insomnia
- (2015) Eliza Sutton Drug Design Development and Therapy
- Associations between the orexin (hypocretin) receptor 2 gene polymorphism Val308Ile and nicotine dependence in genome-wide and subsequent association studies
- (2015) Daisuke Nishizawa et al. Molecular Brain
- Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
- (2015) Taro Kishi et al. PLoS One
- Hypocretin/Orexin Regulation of Dopamine Signaling and Cocaine Self-Administration Is Mediated Predominantly by Hypocretin Receptor 1
- (2014) Courtney D. Prince et al. ACS Chemical Neuroscience
- Anterior thalamic paraventricular nucleus is involved in intermittent access ethanol drinking: role of orexin receptor 2
- (2014) Jessica R. Barson et al. ADDICTION BIOLOGY
- Orexin/hypocretin role in reward: implications for opioid and other addictions
- (2014) Corey Baimel et al. BRITISH JOURNAL OF PHARMACOLOGY
- Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
- (2014) L. Citrome INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial
- (2014) David Michelson et al. LANCET NEUROLOGY
- Insomniacs get new mechanism sleep drug Belsomra
- (2014) Cormac Sheridan NATURE BIOTECHNOLOGY
- The role of orexin in motivated behaviours
- (2014) Takeshi Sakurai NATURE REVIEWS NEUROSCIENCE
- Hypocretin Receptor 2 Antagonism Dose-Dependently Reduces Escalated Heroin Self-Administration in Rats
- (2014) Brooke E Schmeichel et al. NEUROPSYCHOPHARMACOLOGY
- Neural integration of satiation and food reward: Role of GLP-1 and orexin pathways
- (2014) Diana L. Williams PHYSIOLOGY & BEHAVIOR
- Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area
- (2014) J. W. Muschamp et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Electroencephalographic Power Spectral Density Profile of the Orexin Receptor Antagonist Suvorexant in Patients with Primary Insomnia and Healthy Subjects
- (2014) Junshui Ma et al. SLEEP
- Orexin A attenuates the sleep-promoting effect of adenosine in the lateral hypothalamus of rats
- (2014) Yanping Cun et al. Neuroscience Bulletin
- Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonism
- (2014) Christine Dugovic et al. Frontiers in Neuroscience
- LSN2424100: a novel, potent orexin-2 receptor antagonist with selectivity over orexin-1 receptors and activity in an animal model predictive of antidepressant-like efficacy
- (2014) Thomas E. Fitch et al. Frontiers in Neuroscience
- Effects of a newly developed potent orexin-2 receptor-selective antagonist, compound 1 m, on sleep/wakefulness states in mice
- (2014) Keishi Etori et al. Frontiers in Neuroscience
- Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
- (2014) Jiann Wei Yeoh et al. Frontiers in Neuroscience
- The hypocretin/orexin antagonist almorexant promotes sleep without impairment of performance in rats
- (2014) Stephen R. Morairty et al. Frontiers in Neuroscience
- The Hypocretin/Orexin Receptor-1 as a Novel Target to Modulate Cannabinoid Reward
- (2013) África Flores et al. BIOLOGICAL PSYCHIATRY
- Identification of a Novel Series of Orexin Receptor Antagonists with a Distinct Effect on Sleep Architecture for the Treatment of Insomnia
- (2013) Claudia Betschart et al. JOURNAL OF MEDICINAL CHEMISTRY
- Anxiolytic function of the orexin 2/hypocretin A receptor in the basolateral amygdala
- (2013) David H. Arendt et al. PSYCHONEUROENDOCRINOLOGY
- Almorexant Promotes Sleep and Exacerbates Cataplexy in a Murine Model of Narcolepsy
- (2013) Sarah Wurts Black et al. SLEEP
- Central functions of the orexinergic system
- (2013) Xiao-Yang Zhang et al. Neuroscience Bulletin
- Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far
- (2013) África Flores et al. Frontiers in Neuroscience
- Distinct effects of IPSU and suvorexant on mouse sleep architecture
- (2013) Daniel Hoyer et al. Frontiers in Neuroscience
- Discovery of Dual Orexin Receptor Antagonists (DORAs) for the Treatment of Insomnia
- (2012) Paul J. Coleman et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Dual orexin receptor antagonism by almorexant does not potentiate impairing effects of alcohol in humans
- (2012) Matthias Hoch et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The dual orexin receptor antagonist almorexant, alone and in combination with morphine, cocaine and amphetamine, on conditioned place preference and locomotor sensitization in the rat
- (2012) Michel Alexander Steiner et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Orexin receptor antagonism for treatment of insomnia: A randomized clinical trial of suvorexant
- (2012) W. J. Herring et al. NEUROLOGY
- Neurogenesis-Independent Antidepressant-Like Effects on Behavior and Stress Axis Response of a Dual Orexin Receptor Antagonist in a Rodent Model of Depression
- (2012) Mathieu Nollet et al. NEUROPSYCHOPHARMACOLOGY
- Differential Effects of a Dual Orexin Receptor Antagonist (SB-649868) and Zolpidem on Sleep Initiation and Consolidation, SWS, REM Sleep and EEG Power Spectra in a Model of Situational Insomnia
- (2012) Paolo Bettica et al. NEUROPSYCHOPHARMACOLOGY
- Activation of the Orexin 1 Receptor is a Critical Component of CO2-Mediated Anxiety and Hypertension but not Bradycardia
- (2012) Philip L Johnson et al. NEUROPSYCHOPHARMACOLOGY
- The social defeat animal model of depression shows diminished levels of orexin in mesocortical regions of the dopamine system, and of dynorphin and orexin in the hypothalamus
- (2012) C. Nocjar et al. NEUROSCIENCE
- Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network
- (2012) Philip L. Johnson et al. PHYSIOLOGY & BEHAVIOR
- The Dual Orexin/Hypocretin Receptor Antagonist, Almorexant, in the Ventral Tegmental Area Attenuates Ethanol Self-Administration
- (2012) Subhashini Srinivasan et al. PLoS One
- The Dual Orexin Receptor Antagonist Almorexant Induces Sleep and Decreases Orexin-Induced Locomotion by Blocking Orexin 2 Receptors
- (2012) Géraldine M. Mang et al. SLEEP
- The Orexin Antagonist SB-649868 Promotes and Maintains Sleep in Men with Primary Insomnia
- (2012) Paolo Bettica et al. SLEEP
- Orexin-1 receptor antagonist SB-334867 reduces the acquisition and expression of cocaine-conditioned reinforcement and the expression of amphetamine-conditioned reward
- (2011) Daniel M. Hutcheson et al. BEHAVIOURAL PHARMACOLOGY
- Hypocretin/Orexin Signaling in the Hypothalamic Paraventricular Nucleus is Essential for the Expression of Nicotine Withdrawal
- (2011) Ainhoa Plaza-Zabala et al. BIOLOGICAL PSYCHIATRY
- Promotion of Sleep by Suvorexant—A Novel Dual Orexin Receptor Antagonist
- (2011) Christopher J. Winrow et al. JOURNAL OF NEUROGENETICS
- Differential Roles of Orexin Receptor-1 and -2 in the Regulation of Non-REM and REM Sleep
- (2011) M. Mieda et al. JOURNAL OF NEUROSCIENCE
- Pharmacological characterization of MK-6096 – A dual orexin receptor antagonist for insomnia
- (2011) Christopher J. Winrow et al. NEUROPHARMACOLOGY
- Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostasis and arousal
- (2011) Takeshi Sakurai et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Orexin Signaling Via the Orexin 1 Receptor Mediates Operant Responding for Food Reinforcement
- (2010) Ruth Sharf et al. BIOLOGICAL PSYCHIATRY
- Discovery of 3,9-diazabicyclo[4.2.1]nonanes as potent dual orexin receptor antagonists with sleep-promoting activity in the rat
- (2010) Paul J. Coleman et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Orexin Receptor Antagonism, a New Sleep-Promoting Paradigm: An Ascending Single-Dose Study With Almorexant
- (2010) P Hoever et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Knockdown of orexin type 1 receptor in rat locus coeruleus increases REM sleep during the dark period
- (2010) Lichao Chen et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- The Orexin-1 Receptor Antagonist SB-334867 Reduces Alcohol Relapse Drinking, but not Alcohol-Seeking, in Alcohol-Preferring (P) Rats
- (2010) Ronnie Dhaher et al. Journal of Addiction Medicine
- Differential Effects of the Dual Orexin Receptor Antagonist Almorexant and the GABAA-α1 Receptor Modulator Zolpidem, Alone or Combined with Ethanol, on Motor Performance in the Rat
- (2010) Michel A Steiner et al. NEUROPSYCHOPHARMACOLOGY
- Orexin mediates morphine place preference, but not morphine-induced hyperactivity or sensitization
- (2009) Ruth Sharf et al. BRAIN RESEARCH
- Discovery of a Potent, CNS-Penetrant Orexin Receptor Antagonist Based on anN,N-Disubstituted-1,4-diazepane Scaffold that Promotes Sleep in Rats
- (2009) David B. Whitman et al. ChemMedChem
- Blockade of Orexin-1 Receptors Attenuates Orexin-2 Receptor Antagonism-Induced Sleep Promotion in the Rat
- (2009) C. Dugovic et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A key role for orexin in panic anxiety
- (2009) Philip L Johnson et al. NATURE MEDICINE
- The orexin-1 receptor antagonist SB-334867 reduces amphetamine-evoked dopamine outflow in the shell of the nucleus accumbens and decreases the expression of amphetamine sensitization
- (2009) Davide Quarta et al. NEUROCHEMISTRY INTERNATIONAL
- Orexin Mediates the Expression of Precipitated Morphine Withdrawal and Concurrent Activation of the Nucleus Accumbens Shell
- (2008) Ruth Sharf et al. BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More